'We seem to be in a situation where we can do little, and nothing needs to be done anyway.' Photograph: ANI Photo As India's COVID-19 daily case count dips below the 100-mark, approvals for......
Codeine-based formulations are under the scanner for misuse as a narcotic product. IMAGE: In July, the government for the first time allowed a private company, Bajaj Healthcare, to process opium......
The Standing Technical Sub-Committee (STSC) of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended reducing the gap between the second and precaution doses of......
'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.' IMAGE: COVID-19 vaccination in Jaipur,......
Covaxin has shown that it has a very good immune response in children in trials, Dr N K Arora, chairman of Covid Task Force working group, National Technical Advisory Group on......
The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of......
The Delhi high court had earlier allowed Indian pharma major Wockhardt to sell its Ace Proxyvon tablets, which is a mixture of three salts -- aceclofenac, paracetamol and rabeprazol -- a......
The original list had named 349 drugs, but 15 drugs, which include cough and cold medicines Phensedyl and Tixylix, approved prior to 1988, have been kept outside the purview of the ban The health......
Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma). The......
Experts believe the move will have little impact given limited production of generic drugs and authority of doctors in prescribing medicines. The government has made it mandatory for all chemists......